Book contents
- Introduction to Psychiatry
- Introduction to Psychiatry
- Copyright page
- Contents
- Contributors
- 1 Introduction
- 2 Clinical Neuroscience
- 3 Introduction to the Patient Interview
- 4 Mood Disorders
- 5 Schizophrenia Spectrum and Other Psychotic Disorders
- 6 Anxiety Disorders
- 7 Obsessive-Compulsive and Related Disorders
- 8 Disorders Related to Stress and Trauma
- 9 Substance Use Disorders
- 10 Personality Disorders
- 11 Neurocognitive Disorders
- 12 Feeding and Eating Disorders
- 13 Child Psychiatry and Neurodevelopmental Disorders
- 14 Sleep Disorders
- 15 Psychopharmacology and Neurotherapeutics
- 16 Psychosocial Interventions
- 17 Psychiatric Evaluation in the Medical Setting
- 18 Psychiatry of Gender and Sexuality
- 19 Health Policy and Population Health in Behavioral Health Care in the United States
- 20 Global Health and Mental Health Care Delivery in Low-Resource Settings
- Index
- References
9 - Substance Use Disorders
Published online by Cambridge University Press: 22 July 2021
Book contents
- Introduction to Psychiatry
- Introduction to Psychiatry
- Copyright page
- Contents
- Contributors
- 1 Introduction
- 2 Clinical Neuroscience
- 3 Introduction to the Patient Interview
- 4 Mood Disorders
- 5 Schizophrenia Spectrum and Other Psychotic Disorders
- 6 Anxiety Disorders
- 7 Obsessive-Compulsive and Related Disorders
- 8 Disorders Related to Stress and Trauma
- 9 Substance Use Disorders
- 10 Personality Disorders
- 11 Neurocognitive Disorders
- 12 Feeding and Eating Disorders
- 13 Child Psychiatry and Neurodevelopmental Disorders
- 14 Sleep Disorders
- 15 Psychopharmacology and Neurotherapeutics
- 16 Psychosocial Interventions
- 17 Psychiatric Evaluation in the Medical Setting
- 18 Psychiatry of Gender and Sexuality
- 19 Health Policy and Population Health in Behavioral Health Care in the United States
- 20 Global Health and Mental Health Care Delivery in Low-Resource Settings
- Index
- References
Summary
Substance use disorders are highly prevalent, affecting millions of Americans directly (social, occupational, and health problems) and indirectly (billions of dollars in health care costs and lost revenues due to disability). This section briefly introduces the chemical classification and neurobehavioral properties of the most commonly misused substances.
- Type
- Chapter
- Information
- Introduction to PsychiatryPreclinical Foundations and Clinical Essentials, pp. 179 - 232Publisher: Cambridge University PressPrint publication year: 2021
References
Primary Sources
Galanter, M., and Kleber, H. D. (eds.) (2015). The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 5th ed. Arlington, VA: American Psychiatric Publishing.Google Scholar
Miller, W. R., and Rollnick, S. (2013). Motivational Interviewing: Helping People Change (Applications of Motivational Interviewing), 3rd ed. New York: Guilford Press.Google ScholarPubMed
Secondary Sources
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., and the COMBINE Work Group (2006). Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial. JAMA, 295 (17), 2003–2017.CrossRefGoogle Scholar
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., and Goldman, D. (2008). An Evaluation of Mu-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Arch Gen Psychiatry, 65 (2), 135–144.CrossRefGoogle ScholarPubMed
Carliner, H., Keyes, K., and McLaughlin, K. (2016). Childhood Trauma and Illicit Drug Use in Adolescence: A Population-Based National Comorbidity Survey Replication-Adolescent Supplement Study. J Am Acad Child Adolesc Psychiatry 55 (8), 701–708.CrossRefGoogle ScholarPubMed
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., and the Buprenorphine/Naloxone Collaborative Group (2003). Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone. N Engl J Med, 349 (10), 949–958.CrossRefGoogle ScholarPubMed
Project MATCH Research Group (1998). Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three-Year Drinking Outcomes. Alcoholism: Clinical and Experimental Research, 22, 1300–1311.Google Scholar
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (July 17, 2014). The TEDS Report: Age of Substance Use Initiation among Treatment Admissions Aged 18 to 30. Rockville, MD.Google Scholar
Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., et al. (2011). Adjunctive Counseling during Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. Arch Gen Psychiatry 68 (12), 1238–1246.CrossRefGoogle ScholarPubMed
Kleber, H. D., Weiss, R. D., Anton, R. F., George, T. P., Greenfield, S. F., et al. (2007). Work Group on Substance Use Disorders; American Psychiatric Association; Steering Committee on Practice Guidelines. Treatment of Patients with Substance Use Disorders, 2nd Edition. American Psychiatric Association. Am J Psychiatry, 164 (4 suppl.), 5–123.Google Scholar
SAMHSA-HRSA Center for Integrated Health Solutions (CIHS), http://wwwwww.integration.samhsa.govGoogle Scholar